Hyperpigmentation Treatment
| Condition | Hyperpigmentation (PIH, Sun Spots) |
|---|---|
| Key Drivers | UV Radiation, Inflammation, Hormones, Heat |
| Core Treatments | Hydroquinone, Retinoids, Azelaic Acid, TXA, Kojic Acid |
| Goals | Fade Spots, Even Tone, Prevent Rebound |
| Improvement Timeline | 4–8 weeks (PIH), 12–16 weeks (Stubborn Pigment) |
Hyperpigmentation is a descriptive term, not a single diagnosis. It means areas of skin look darker than your surrounding skin because extra melanin has been made and deposited there. Sun exposure is the most common driver, but darkening can also follow pimples, eczema or minor trauma (post-inflammatory hyperpigmentation), be hormonally influenced as in melasma (often triggered by hormonal changes, especially during pregnancy or hormonal shifts), or relate to medications and procedures [1–4].
It can appear as scattered freckles (small, flat spots on the skin), well-defined sun spots, mottled patches, or broad symmetrical areas on the cheeks, forehead and upper lip. Melasma is a type of hyperpigmentation caused by hormonal fluctuations, leading to uneven dark patches on the face. In deeper skin tones it often looks slate-brown or grey rather than red-brown [1–2]. Most hyperpigmentation is harmless, although any new, changing, or very dark solitary spot should be assessed by a clinician to rule out other causes, as hyperpigmentation can be a symptom of an underlying skin condition. The right hyperpigmentation treatment depends on identifying what type of pigment you have and what is driving it [3–4].
What causes hyperpigmentation?
Hyperpigmentation happens when skin makes and deposits extra melanin, the pigment that gives skin its colour. It can be focal or diffuse: several factors, including environmental, hormonal and genetic influences, can contribute to the development of conditions like melasma, making its pathogenesis multifactorial.
Focal hyperpigmentation
Focal hyperpigmentation most often follows inflammation or injury, for example after acne, eczema, a cut or a burn. Some prescription treatments can target both acne and hyperpigmentation, offering dual benefits for people dealing with these overlapping concerns. It can also occur in some autoimmune conditions like cutaneous lupus. Very importantly, new or changing dark patches can, in some cases, be due to skin cancers such as melanoma, so anything uncertain or evolving should be assessed by a doctor [2–4].
Diffuse hyperpigmentation
Diffuse hyperpigmentation involves more widespread darkening and can be triggered by medications, internal medical conditions or, rarely, cancers. Medicines that are known to darken skin in some people include amiodarone, antimalarials, certain chemotherapies and some antibiotics. Systemic conditions linked with diffuse darkening include Addison's disease, haemochromatosis and primary biliary cholangitis. Because internal causes are possible, sharing your full medical history and medication list with your clinician is important when hyperpigmentation is being evaluated [3–5].
At a cellular level, hyperpigmentation results from over-production and transfer of melanin. UV radiation is the most common trigger. When skin senses UV, melanocytes, the pigment-producing cells, ramp up melanin as a protective response. Melanin acts like a natural sunscreen by absorbing and scattering UV, but the extra pigment is then handed off to surrounding skin cells, which makes dark patches more visible. Inflammation from acne, eczema, scratching or sunburn can amplify this process and deepen existing colour changes [1–3].
In short, sun exposure and inflammation are the usual culprits, but medications and internal health conditions can also play a role. Accurate diagnosis guides safe hyperpigmentation treatment, so a clinical review is the best starting point, especially for new, changing or very dark solitary spots [3–5].
Risk factors for hyperpigmentation
People with darker skin tones (Fitzpatrick IV–VI) are more prone to hyperpigmentation because their skin produces more melanin and responds strongly after inflammation. High UV or heat exposure increases risk, so outdoor work, frequent sun, tanning, or hot environments often lead to solar lentigines (also known as liver spots), which are flat, light brown pigmentation areas commonly appearing on the hands and face, and can worsen melasma. Hormonal factors also matter, so pregnancy, hormonal contraception, HRT, and thyroid disease are linked with melasma susceptibility. Acne and other inflammatory skin conditions, along with rubbing or picking, raise the chance of lingering dark marks. Recent procedures or irritation from peels, lasers, microneedling, waxing, or harsh skincare can trigger post-inflammatory hyperpigmentation, with individuals with darker skin tones having an increased risk of side effects or complications from these treatments. Certain medicines and chemicals, like some antibiotics, antimalarials, amiodarone, chemotherapy agents, and photosensitising fragrances, can darken skin, and some systemic conditions such as Addison's disease, haemochromatosis, or liver disease may cause diffuse hyperpigmentation over time [1–5].
The importance of sun protection in hyperpigmentation treatment
Sun protection is the cornerstone of any effective hyperpigmentation treatment. Prolonged sun exposure is a leading cause of increased melanin production, which can worsen existing dark spots, age spots and post-inflammatory hyperpigmentation. Even brief periods outdoors can trigger new pigmentation or deepen uneven skin tone, especially if you are already treating hyperpigmentation.
To prevent further sun damage and support a more even skin pigmentation, it is essential to make sun protection a daily habit. This means applying a broad-spectrum sunscreen with a high SPF every morning, even on cloudy days or when indoors near windows, as UV light and visible light can both contribute to pigmentation. Reapply sunscreen every two hours if you are outside, and after swimming or sweating.
Wearing protective clothing (such as wide-brimmed hats, sunglasses and long sleeves) adds another layer of defence, especially during peak UV hours. Seeking shade whenever possible and avoiding unnecessary sun exposure can further reduce your risk of developing new dark patches or worsening existing ones.
By prioritising sun protection, you not only help prevent new hyperpigmentation but also give your skin the best chance to respond to treatment and maintain a more even skin tone over time.
At-home skincare for hyperpigmentation
A thoughtful at-home skincare routine can make a significant difference in reducing hyperpigmentation and supporting a more even skin tone. Look for skincare products that contain proven ingredients such as vitamin C, kojic acid and azelaic acid. These help to brighten the skin, reduce hyperpigmentation and target dark spots caused by sun damage or post-inflammatory changes.
Regular exfoliation with glycolic acid or other alpha-hydroxy acids can help remove dead skin cells, revealing fresher, more radiant skin underneath and improving the absorption of other active ingredients. However, it is important to choose products that suit your skin type, especially if you have sensitive skin, as over-exfoliation or harsh ingredients can cause irritation and potentially worsen hyperpigmentation.
Daily use of a broad-spectrum sunscreen with a high SPF is non-negotiable, as it protects your skin from further sun damage and helps prevent new pigmentation from forming. Consistency is key. Incorporate these steps into your morning and evening routines, and adjust your products as your skin's needs change.
If you are unsure which products are right for your skin, or if over-the-counter options have not delivered results, consider seeking personalised advice from a skincare professional. Prescription Skin offers tailored solutions that can complement your at-home efforts and help you achieve clearer, more even skin.
Managing hyperpigmentation on darker skin
Darker skin tones are uniquely prone to post-inflammatory hyperpigmentation and uneven pigmentation, making a gentle, targeted approach essential. Because darker skin produces more melanin in response to inflammation or sun exposure, even minor skin injuries or irritation can leave lingering dark patches.
To effectively treat hyperpigmentation on darker skin, start with fragrance-free, non-irritating skincare products designed for your skin type. Harsh ingredients or aggressive exfoliation can do more harm than good, so opt for gentle cleansers and moisturisers that support your skin barrier. Ingredients like azelaic acid and kojic acid can help fade dark spots without increasing sensitivity.
Sun protection is especially important for darker skin types, as repeated sun exposure can intensify pigmentation and make existing spots more stubborn. Apply a broad-spectrum sunscreen with a high SPF every day, and reinforce your routine with protective clothing and shade-seeking habits.
For persistent or severe hyperpigmentation, professional treatments such as chemical peels or laser therapy may be considered. However, these should always be performed by practitioners experienced with darker skin tones to minimise the risk of further pigmentation changes. A personalised treatment plan, developed in consultation with a dermatologist or prescription skincare provider, ensures your unique skin concerns are addressed safely and effectively.
By combining gentle at-home care, diligent sun protection and professional guidance, you can manage hyperpigmentation and achieve a more even, radiant skin tone, no matter your skin colour.
Prescription hyperpigmentation treatment: what works
Hydroquinone
Hydroquinone reduces unwanted pigment by blocking tyrosinase, the key enzyme that starts melanin production, and by interfering with melanosome formation and transfer. Hydroquinone is regarded as the gold standard for the treatment of facial hyperpigmentation. Used once or twice daily in short cycles, it gradually lightens patches of melasma, sun spots, and post-inflammatory hyperpigmentation. Hydroquinone's long-term use can lead to a rare condition called ochronosis, which causes blue-black skin discolouration. Clinicians often taper the frequency or rotate off to maintenance to minimise irritation and rebound. Strict daily photoprotection is essential during and after treatment or results will stall [6–10].
Retinoids
Retinoids accelerate epidermal turnover and improve even dispersion of pigment within the skin. Over time they help fade post-acne marks and mottled photoageing, and they boost the performance of other lightening agents by improving penetration. Retinoids also stimulate collagen production, which helps reduce signs of ageing such as fine lines and wrinkles. They are also ideal for maintenance after stronger protocols, keeping tone more even while supporting collagen and texture [9–11].
Azelaic acid
Azelaic acid is effective in treating pigmentary disorders by acting as a tyrosinase inhibitor and producing selective cytotoxic effects on melanocytes. Azelaic acid calms inflammation and reduces oxidative stress that drives post-inflammatory darkening. It is well suited to sensitive or acne-prone skin because it helps with bumps and redness while gradually evening tone. Many clinicians use it as a primary option for PIH, as a hydroquinone-alternative, or as a maintenance step between hydroquinone cycles [12–13].
Tranexamic acid
Tranexamic acid reduces melanocyte activation signals that follow UV exposure and inflammation by modulating the plasminogen–plasmin pathway. It is helpful for melasma that is slow to respond or relapses easily. Oral use requires screening for clotting risk and medical supervision. Topical forms are often combined with other agents in custom hyperpigmentation treatment formulas [14–16].
Kojic Acid
Kojic acid is an effective depigmenting agent that works by inhibiting the catecholase activity of tyrosinase.
Why prescription hyperpigmentation treatment outperforms over-the-counter
Prescription treatment beats DIY brightening because it targets the type of pigment you have with medical-grade actives at effective strengths, then sequences them safely. Prescription treatments for hyperpigmentation can be tailored to individual skin types and concerns through telehealth. Your clinician can combine ingredients to take advantage of their effects, like hydroquinone to quiet tyrosinase, a retinoid to speed turnover, azelaic acid and niacinamide to calm inflammation, and tranexamic acid for melasma. You also get tinted SPF and maintenance built in, especially when using iron oxide-containing sunscreens, which provide enhanced protection against visible light. This is particularly beneficial for melasma and patients with skin of colour, helping results hold rather than yo-yo. Plus, a proper assessment rules out look-alikes and medication causes, keeping the plan effective and safe [6–16].
What to expect from hyperpigmentation treatment
- Weeks 2–4: Early "brightness" changes and a more even look at the edges of dark patches. Post-acne marks often look a touch lighter. Skin may feel smoother if a retinoid is included. Any irritation from new actives should be mild and settling by now with moisturiser support and strict SPF [9–11,13].
- Weeks 4–8: Visible fading becomes more apparent for post-inflammatory hyperpigmentation. Hydroquinone or triple-combination protocols usually show clear movement in this window. Azelaic acid and prescription retinoids continue to even out tone and help new marks resolve faster. Expect steadier progress with daily broad-spectrum, ideally tinted SPF to block UV and visible light. Winter is often an ideal season for pigmentation treatments, as reduced sun exposure can improve outcomes and help maintain results [6–11,13,15–16].
- Weeks 8–12: Melasma typically needs this longer runway. Triple-combination therapy and regimens that include tranexamic acid often show meaningful improvement now. If progress stalls, it is usually a consistency or photoprotection issue, so double-check morning SPF, reapplication, hats and shade [8–10,14–16].
- Months 3–6: Colour keeps softening and mottling blends into surrounding skin. Many plans transition from "active clearance" to maintenance, for example cycling off hydroquinone, continuing a retinoid and azelaic acid, and keeping daily tinted SPF. Any in-clinic procedures, if chosen, are spaced and always paired with rigorous sun and heat avoidance to reduce rebound [6–7,9–11,13,15–16].
- Beyond 6 months: Results are maintained rather than chased. Retinoids, azelaic acid or tranexamic acid are used as anchors, with seasonal or short re-introductions of hydroquinone if spots return. Ongoing photoprotection is what prevents back-sliding [6–16].
Start your hyperpigmentation treatment with Prescription Skin
Getting effective hyperpigmentation treatment in Australia no longer means waiting weeks for a dermatologist appointment. Start with a quick online skin assessment and a medical review with an AHPRA-registered doctor. We identify the type of pigment you have, rule out underlying causes, then build a custom formula matched to your skin tone, sensitivity and goals. Custom-compounded prescription skincare formulas can be delivered directly to your door through our telehealth services. Your plan is adjusted over follow-ups, for example, titrating retinoid strength, cycling hydroquinone safely, or adding tranexamic acid if melasma proves stubborn. Clear, step-by-step instructions ensure you know what to use, when to use it, and how to manage temporary irritation while results build.
Start with a quick skin assessment →
Find out how a personalised prescription formula could work for your skin at Prescription Skin.
References
- Taylor SC, Cook-Bolden F, Rahman Z, Strachan D. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl):S98–S106. ↩︎
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31. ↩︎
- Kwon SH, Hwang YJ, Lee SK, Park KC. Melasma: updates in pathogenesis and treatment. Ann Dermatol. 2019;31(4):367–376. ↩︎
- Pandya AG, Hynan LS, Bhore R, et al. Reliability assessment and validation of the Melasma Area and Severity Index. Evidence-based review of melasma treatments. J Am Acad Dermatol. 2016;74(4):707–721.e8. ↩︎
- Dereure O. Drug-induced skin pigmentation. Am J Clin Dermatol. 2001;2(4):253–262. ↩︎
- Sheth VM, Pandya AG. Melasma: a comprehensive update. Am J Clin Dermatol. 2011;12(2):87–99. ↩︎
- Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol. 1975;111(1):40–48. ↩︎
- Torok HM. A comprehensive review of the efficacy of a triple-combination cream for facial melasma. Cutis. 2006;77(5):291–296. ↩︎
- Kang S, Fisher GJ, Voorhees JJ. Photoaging and topical tretinoin therapy. N Engl J Med. 2001;345(9):720–726. ↩︎
- Weiss JS, Ellis CN, Headington JT, et al. Topical tretinoin improves photoaged skin. JAMA. 1988;259(4):527–532. ↩︎
- Griffiths CEM, Finkel LJ, Ditre CM, et al. Topical tretinoin for photoaging. N Engl J Med. 1993;329(8):530–535. ↩︎
- Fitton A, Goa KL. Azelaic acid: a review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs. 1991;41(5):780–798. ↩︎
- Draelos ZD. A clinical evaluation of a 20% azelaic acid cream in the treatment of facial hyperpigmentation. Cutis. 2007;79(5):397–403. ↩︎
- Maeda K, Naganuma M. Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation–induced pigmentation. Arch Dermatol Res. 1998;290(8):375–381. ↩︎
- Del Rosario E, Florez-White M, Helfrich YR, Chien AL. Tranexamic acid for melasma: A review and meta-analysis. Australas J Dermatol. 2018;59(3):e168–e173. ↩︎
- Lee JH, Park JG, Lim SH, et al. Oral tranexamic acid for melasma. J Dermatolog Treat. 2016;27(4):373–377. ↩︎
Medically Reviewed Content
- Written by: The Prescription Skin Editorial Team
- Medically Reviewed by: Dr Mitch Bishop (AHPRA Registered Practitioner: MED0002309948)
- Last Updated: February 2026
This content is for informational purposes only and does not constitute medical advice. Treatment is subject to consultation and approval by our Australian-registered doctors.